Studies on the purification of normal immunoglobulin for intravenous use
Walsh, J.J.
Developments in Biological Standardization 27: 31-36
1974
ISSN/ISBN: 0301-5149 PMID: 4376994 Document Number: 71996
Document emailed within 1 workday
Related Documents
Börner, P.; Deicher, H.; Bähr, I.; Chalius, H.H.; Ghani, G.; Geldmacher, H.; Henke, I.W.; Kindermann, L.; Marks, V. 1976: Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion Geburtshilfe und Frauenheilkunde 36(6): 485-492Tsutsumi, Y. 1984: Relation between frequency of the development of enzyme-bound immunoglobulin and pathophysiology. LDH-binding immunoglobulin-- estimation of its frequency in normal subjects Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 60: 85-89
Nakada, T. 2016: Intravenous immunoglobulin therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 6): 527-531
Ventura, A.; Florean, P.; Pascone, R.; Perini, R.; Pocecco, M.; Lepore, L. 1986: Intravenous immunoglobulin in immune neutropenia Helvetica Paediatrica Acta 41(6): 495-500
Namiki, A.; Asai, H.; Kenmotsu, O.; Takahashi, T. 1975: Studies on intravenous anesthesia (24)--pharmacological effects of various intravenous anesthesics on the isolated intestine of the rabbit Masui. Japanese Journal of Anesthesiology 24(7): 714-721
Nydegger, U.E. 1983: Evaluation criteria for intravenous immunoglobulin G preparations Presse Medicale 12(41): 2619-2624
Taneichi, H.; Miyawaki, T. 2011: High-dose intravenous immunoglobulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 69(3): 515-519
Gadoth, N.; Melamed, E.; Miller, A.; Steiner, I.; Abramsky, O. 1999: Intravenous immunoglobulin treatment in multiple sclerosis Neurology 52(1): 214-215
Tuohy, P.G. 1992: Intravenous immunoglobulin in chronic relapsing polyneuropathy New Zealand Medical Journal 105(928): 60-61
Komoly, S.ám. 2014: Intravenous immunoglobulin therapy in neuroimmunological disorders Ideggyogyaszati Szemle 67(7-8): 281-282
Rüfenacht, R.; Morell 1991: Immunochemical characterization of intravenous immunoglobulin preparations Allergologia et Immunopathologia 19(5): 197-200
Llombart, M.; García-Abujeta, J.L.; Sánchez-Pérez, R.M.; Hernando de Larramendi, C. 2007: Pompholyx induced by intravenous immunoglobulin therapy Journal of Investigational Allergology and Clinical Immunology 17(4): 277-278
Rault, R.; Piraino, B.; Johnston, J.R.; Oral, A. 1991: Pulmonary and renal toxicity of intravenous immunoglobulin Clinical Nephrology 36(2): 83-86
Ishii, N.; Hashimoto, T. 2010: Intravenous immunoglobulin (TVIG) therapy in pemphigus Nihon Rinsho. Japanese Journal of Clinical Medicine 68(11): 2143-2146
Lucas, G.S.; Jobbins, K.; Bloom, A.L. 1987: Intravenous immunoglobulin and blood group antibodies Lancet 2(8561): 742
Tsai, C.-P. 2010: Pharmacoeconomics of intravenous immunoglobulin in various neurological disorders Acta Neurologica Taiwanica 19(4): 303-308
Blanchette, V.S.; Kirby, M.A.; Turner, C. 1992: Role of intravenous immunoglobulin G in autoimmune hematologic disorders Seminars in Hematology 29(3 Suppl 2: 72-82
Ganly, P.; Spearing, R. 2006: Treatment with intravenous immunoglobulin is not a panacea but should be limited to those who can benefit New Zealand Medical Journal 119(1246): U2335
Guencheva, G. 1984: Requirements and characteristics of various immunoglobulin preparations for intravenous application Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 30(1): 21-23
Lever, A.M.; Webster, A.D.; Brown, D.; Thomas, H.C. 1984: Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin Lancet 2(8411): 1062-1064